Aequus Pharmaceuticals Inc. (AQS.V)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.29 Million | -1.95 Million | -1.17 Million | -804.9 Thousand | -1.62 Million | -2.57 Million |
| Net Income | -2.96 Million | -3.21 Million | -1.8 Million | -1.04 Million | -3.1 Million | -2.8 Million |
| Depreciation & Amortization | 138.16 Thousand | 129.83 Thousand | 128.1 Thousand | 210.96 Thousand | 309.06 Thousand | 187.79 Thousand |
| Deferred income taxes | - | 273.43 Thousand | -3280.00 | - | 478.94 Thousand | - |
| Stock-based compensation | 50.91 Thousand | 40.94 Thousand | 215.75 Thousand | 297.64 Thousand | 201 Thousand | 346.03 Thousand |
| Change in working capital | 415.07 Thousand | 445.57 Thousand | 28.91 Thousand | -521.7 Thousand | 216.71 Thousand | -366.65 Thousand |
| Other non-cash items | 117.72 Thousand | 367.68 Thousand | 267.88 Thousand | 253.54 Thousand | 271.19 Thousand | 62.86 Thousand |
| Investing Cash Flow | - | - | -507.96 Thousand | -12.31 Thousand | -2679.00 | -11.36 Thousand |
| Investments in PPE | -5.00 | - | -4121.00 | -12.31 Thousand | -2679.00 | -11.36 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -503.84 Thousand | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -503.83 Thousand | - | - | - |
| Financing Cash Flow | 2.21 Million | -189.18 Thousand | 2.39 Million | 2.05 Million | 1.74 Million | 1.79 Million |
| Debt repayment | -2.37 Million | -38 Thousand | -147.5 Thousand | -143.82 Thousand | -140.14 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 2.54 Million | 2.15 Million | 220.00 | 1.79 Million |
| Other Financing Activities | 2.37 Million | -151.18 Thousand | 2.54 Million | 40 Thousand | 1.88 Million | 1.79 Million |
| Accounts receivables | 278.41 Thousand | 618.22 Thousand | -161.56 Thousand | -223.21 Thousand | 174.85 Thousand | -301.08 Thousand |
| Accounts payables | 27.61 Thousand | -90.18 Thousand | 141.65 Thousand | -95.4 Thousand | 17.63 Thousand | - |
| Inventory | -29.92 Thousand | 46 Thousand | -16.5 Thousand | -117.89 Thousand | 7264.00 | -12.69 Thousand |
| Other working capital | 138.97 Thousand | -128.46 Thousand | 65.33 Thousand | -85.18 Thousand | 16.95 Thousand | -52.87 Thousand |
| Cash at beginning of period | 249.81 Thousand | 2.39 Million | 1.71 Million | 484.5 Thousand | 369.89 Thousand | 1.16 Million |
| Cash at end of period | 170.19 Thousand | 249.81 Thousand | 2.43 Million | 1.71 Million | 484.5 Thousand | 369.89 Thousand |
| Capital Expenditure | -5.00 | - | -4121.00 | -12.31 Thousand | -2679.00 | -11.36 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -79.61 Thousand | -2.14 Million | 717.56 Thousand | 1.23 Million | 114.61 Thousand | -794.62 Thousand |
| Free Cash Flow | -2.29 Million | -1.95 Million | -1.17 Million | -817.22 Thousand | -1.63 Million | -2.58 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -683.03 Thousand | -662.08 Thousand | -2.96 Million | -715.87 Thousand | -803.65 Thousand | -700.87 Thousand |
| Depreciation & Amortization | 33.08 Thousand | 33.08 Thousand | 138.16 Thousand | 33.92 Thousand | 34.74 Thousand | 34.74 Thousand |
| Deferred income taxes | - | - | - | - | 35.66 Thousand | 50.17 Thousand |
| Stock-based compensation | 17.45 Thousand | 7855.00 | 50.91 Thousand | 8837.00 | 11.01 Thousand | 26.44 Thousand |
| Change in working capital | -148.07 Thousand | 84.2 Thousand | 415.07 Thousand | -240.6 Thousand | 87.56 Thousand | 147.28 Thousand |
| Other non-cash items | 74.47 Thousand | -4169.00 | 117.72 Thousand | 339.96 Thousand | -15.06 Thousand | -32.93 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 508.14 Thousand | 593.55 Thousand | 2.21 Million | 960.28 Thousand | 731.36 Thousand | 461.36 Thousand |
| Debt repayment | -41.86 Thousand | -635.41 Thousand | -2.37 Million | -1 Million | -770 Thousand | -500 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 550 Thousand | 635.41 Thousand | 2.37 Million | 1 Million | 770 Thousand | 500 Thousand |
| Accounts receivables | -83.75 Thousand | -4440.00 | 278.41 Thousand | 38.13 Thousand | -59.04 Thousand | -8848.00 |
| Accounts payables | 59.76 Thousand | 51.56 Thousand | 27.61 Thousand | -350.42 Thousand | 327.42 Thousand | 118.15 Thousand |
| Inventory | -84.35 Thousand | 46.3 Thousand | -29.92 Thousand | 60.6 Thousand | -152.2 Thousand | 36.8 Thousand |
| Other working capital | 20.03 Thousand | -9220.00 | 138.97 Thousand | 11.07 Thousand | -28.6 Thousand | 1171.00 |
| Cash at beginning of period | 242.04 Thousand | 170.19 Thousand | 249.81 Thousand | 112.02 Thousand | 30.38 Thousand | 44.18 Thousand |
| Cash at end of period | 44.08 Thousand | 242.04 Thousand | 170.19 Thousand | 170.19 Thousand | 112.02 Thousand | 30.38 Thousand |
| Capital Expenditure | 4.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -197.96 Thousand | 71.84 Thousand | -79.61 Thousand | 58.17 Thousand | 81.63 Thousand | -13.79 Thousand |
| Free Cash Flow | -706.1 Thousand | -521.7 Thousand | -2.29 Million | -902.11 Thousand | -649.72 Thousand | -475.15 Thousand |
INFOBEAN
002685
GRLF
6918
UTTAMSUGAR
298540